ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 964

Skin Collagen Synthesis Rates Distinguish Between Early and Late Diffuse Scleroderma Patients

Claire Emson1, Martin Decaris1, Michelle Gatmaitan1, Flora Luo1, Dan Holochwost1, Simplicia FloraCruz1, Thomas Angel1, Kelvin Li1, Marc Hellerstein1, Fredrick M. Wigley2, Scott Turner1,3 and Francesco Boin2, 1KineMed Inc., Emeryville, CA, 2Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 35980 Horton Street, Suite 470, KineMed Inc., Emeryville, CA

Meeting: ACR/ARHP Annual Meeting 2014

Keywords: Collagen, fibrosis and scleroderma

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics I

Session Type: Abstract Submissions (ACR)

Background/Purpose

The synthesis and degradation of extracellular matrix (ECM), particularly collagen, is one of the central mechanisms perturbed in scleroderma (SSc). Understanding the kinetics of this process can be of great value to define disease activity during the course of SSc and to develop better tools to assess with precision response to therapeutic interventions.

Methods

Using a stable isotope (deuterium) labeling method and a new kinetic proteomic approach designed to enrich for ECM, we assessed the turnover of collagen in the skin of SSc subjects. Moreover, we pursued the extraction of different collagen pools based on their solubility to measure kinetics of collagen subtypes and other matrix molecules. Three subpopulations were studied: limited (n=6), diffuse early-active (n=5) and diffuse late-stage SSc (n=6). Subjects were given heavy water for 3 weeks prior to a skin biopsy. Protein, lipid and cell kinetics were measured and correlated to gene array and histology from adjacent biopsies.

Results

Total collagen synthesis rates (% new collagen after 3 weeks of labeling) were significantly higher in late-stage diffuse SSc subjects (5.052%±1.953) compared to early-active (1.986%±0.8226; p=0.0031) or normal subjects (2.237%±0.6365; p=0.0031) demonstrating that fibrotic tissue in these subjects undergoes active remodeling. The microarray data showed that the higher collagen synthesis detected in late diffused patients is significantly associated with the expression of genes involved with fibrosis and cell cycle. When compared to total collagen synthesis rates, kinetic analysis of individual collagen pools revealed that the guanidine soluble collagen (corresponding to recently synthetized uncross-linked collagen and immature matrix) represented a greater proportion of the total collagen pool in the late diffuse subjects that have more established fibrosis.

Conclusion

This study shows that cutaneous fibrosis in late-stage SSc is not a static hypodynamic scarring but rather undergoes active remodeling with a pool of newly synthesized, uncross-linked collagen. These data emphasize that the biological processes and pathogenetic networks driving SSc skin involvement likely change over time with the different stages of the disease.


Disclosure:

C. Emson,

Kinemed,

3;

M. Decaris,

Kinemed,

3;

M. Gatmaitan,

Kinemed,

3;

F. Luo,

Kinemed,

3;

D. Holochwost,

Kinemed,

3;

S. FloraCruz,

Kinemed,

3;

T. Angel,

Kinemed,

3;

K. Li,

Kinemed,

3;

M. Hellerstein,

Kinemed,

3;

F. M. Wigley,
None;

S. Turner,

Kinemed,

3;

F. Boin,
None.

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2014

ACR Meeting Abstracts - https://acrabstracts.org/abstract/skin-collagen-synthesis-rates-distinguish-between-early-and-late-diffuse-scleroderma-patients/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology